12 Best Fundamental Stocks to Buy Now

Page 9 of 11

3. Thermo Fisher Scientific Inc. (NYSE:TMO)

Number of Hedge Fund Holdings: 98

10-Year Revenue Growth Rate: 10.32%

10-Year Net Income Growth Rate: 14.14%

Thermo Fisher Scientific Inc. (NYSE:TMO) is a world-leading provider of scientific instruments, reagents, and consumables to the scientific community, serving a diverse range of customers in the pharmaceutical, biotech, academic, and government sectors.

Thermo Fisher Scientific Inc. (NYSE:TMO) is focused on executing its proven growth strategy, which centers on gaining market share through innovation, expanding its commercial capabilities, and strengthening its position as a trusted partner to its customers. The company is investing heavily in research and development and has a strong pipeline of new products and technologies that are expected to drive growth in the coming years. The company’s recent launches in the areas of precision medicine and advanced materials have been met with strong adoption, and the company is seeing significant opportunities for growth in these areas. Additionally, Thermo Fisher Scientific Inc.’s (NYSE:TMO) accelerated drug development program, which aims to help pharmaceutical and biotech companies bring new medicines to market more quickly, is gaining traction and is expected to be a key driver of growth in the future.

Thermo Fisher Scientific Inc. (NYSE:TMO) is also pursuing external growth opportunities through strategic acquisitions and partnerships. The company recently acquired Olink, a leading provider of proteomics solutions. The acquisition aims to expand the company’s capabilities in the rapidly growing field of proteomics and positions the company for future growth in this area.

Page 9 of 11